Join
Live feed
·
PRReleasevia Quantisnow
Syneos Health Inc. logo

Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone)

ByQuantisnow·Wall Street's wire, on your screen.
SYNH· Syneos Health Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SYNH (Syneos Health Inc.) and more on Quantisnow.